Luís Abegão Pinto, MD, PhD

Central Lisbon Hospital North. Visual Sciences Study Center, Faculty of Medicine, University of Lisbon, Portugal.

1.    Cook C, Foster P. Epidemiology of glaucoma: what's new? Can J Ophthalmol 2012;47:223-6.
2.    Wang D, Huang W, Li Y, et al. Intraocular pressure, central corneal thickness, and glaucoma in chinese adults: the liwan eye study. Am J Ophthalmol 2011;152:454-62.e1.
3.    Jonas JB, Nangia V, Matin A, et al. Intraocular pressure and associated factors: the central India eye and medical study. J Glaucoma 2011;20:405-9.
4.    Jonas JB, Budde WM, Stroux A, et al. Circadian intraocular pressure profiles in chronic open angle glaucomas. J Ophthalmic Vis Res 2010;5:92-100.
5.    Drance SM. What can we learn from the disc appearance about the risk factors in glaucoma? Can J Ophthalmol 2008;43:322-7.
6.    Flammer J, Konieczka K, Flammer AJ. The primary vascular dysregulation syndrome: implications for eye diseases. EPMA J 2013;4:14.
7.    Flammer J, Pache M, Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res 2001;20:319-49.
8.    Mozaffarieh M, Flammer J. New insights in the pathogenesis and treatment of normal tension glaucoma. Curr Opin Pharmacol 2013;13:43-9.
9.    Flammer J, Orgül S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 2002;21:359-93.
10.  Copt RP, Thomas R, Mermoud A. Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma. Arch Ophthalmol 1999;117:14-6.
11.  Shetgar AC, Mulimani MB. The central corneal thickness in normal tension glaucoma, primary open angle glaucoma and ocular hypertension. J Clin Diagn Res 2013;7:1063-7.
12.  Mohamed-Noor J, Bochmann F, Siddiqui MA, et al. Correlation between corneal and scleral thickness in glaucoma. J Glaucoma 2009;18:32-6.
13.  Drance S, Anderson DR, Schulzer M, Group CN-TGS. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol 2001;131:699-708.
14.  Graham SL, Butlin M, Lee M, Avolio AP. Central blood pressure, arterial waveform analysis, and vascular risk factors in glaucoma. J Glaucoma 2013;22:98-103.
15.  Willekens KBataillie SSarens I et al. Funduscopic versus HRT III Confocal Scanner Vertical Cup-Disc Ratio Assessment in Normal Tension and Primary Open Angle Glaucoma (The Leuven Eye Study). Ophthalmic Res 2017; 57(2):100-106
16.  Anderson DR, Drance SM, Schulzer M, Group CN-TGS. Factors that predict the benefit of lowering intraocular pressure in normal tension glaucoma. Am J Ophthalmol 2003;136:820-9.
17.  The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 1998;126:498-505.
18.  Sakata R, Aihara M, Murata H, et al. Contributing factors for progression of visual field loss in normal-tension glaucoma patients with medical treatment. J Glaucoma 2013;22:250-4.
19.  De Moraes CG, Liebmann JM, Greenfield DS, et al. Risk factors for visual field progression in the low-pressure glaucoma treatment study. Am J Ophthalmol 2012;154:702-11.
20.  Lee J, Kong M, Kim J, Kee C. Comparison of Visual Field Progression Between Relatively Low and High Intraocular Pressure Groups in Normal Tension Glaucoma Patients. J Glaucoma 2013 [epub ahead of print].
21.  Anderson DR, Drance SM, Schulzer M, Group CN-TGS. Natural history of normal-tension glaucoma. Ophthalmology 2001;108:247-53.

4th Edition - May 2017